Evidence map›Paper›PMID 19997871›Full record

ReviewMolecular neurobiology2010

Humanin and the receptors for humanin.

Masaaki Matsuoka, Yuichi Hashimoto

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Humanin suppresses receptor activator of nuclear factor-κB ligand-induced osteoclast differentiationThe Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Central effects of humanin on hepatic triglyceride secretion.American journal of physiology. Endocrinology and metabolism · 2015
    Article
  17. Humanin Derivatives Inhibit Necrotic Cell Death in Neurons.Molecular medicine (Cambridge, Mass.) · 2015
    Article
  18. Article
  19. The effects of humanin and its analogues on male germ cell apoptosis induced by chemotherapeutic drugs.Apoptosis : an international journal on programmed cell death · 2015
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Masaaki MatsuokaDepartment of Pharmacology, Tokyo Medical University, Shinjuku-ku, Japan. sakimatu@tokyo-med.ac.jp
Yuichi Hashimoto
Tokyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is a prevalent dementia-causing neurodegenerative disease. Neuronal death is closely linked to the progression of AD-associated dementia. Accumulating evidence has established that a 24-amino-acid bioactive peptide, Humanin, protects neurons from AD-related neuronal death. A series of studies using various murine AD models including familial AD gene-expressing transgenic mice have shown that Humanin is effective against AD-related neuronal dysfunction in vivo. Most recently, it has been shown that Humanin inhibits neuronal cell death and dysfunction by binding to a novel IL-6-receptor-related receptor(s) on the cell surface involving CNTFRalpha, WSX-1, and gp130. These findings suggest that endogenous Humanin [or a Humanin-like substance(s)] may suppress the onset of AD-related dementia by inhibiting both AD-related neuronal cell death and dysfunction.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsBrainCell DeathHumansIntracellular Signaling Peptides and ProteinsMembrane ProteinsNerve Tissue ProteinsNeuronsAmyloid beta-PeptideshumaninIntracellular Signaling Peptides and ProteinsMembrane ProteinsNerve Tissue Proteins

Identifiers

PMID19997871
OpenAlexW1989816925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.